Biomaterials are synthetic or natural materials used to improve or replace the functions of biological systems. Biomaterials (biomaterials) are natural or synthetic special functional materials that are used to contact and interact with living systems and can diagnose, treat, replace, repair, or induce regeneration of their cells, tissues, and organs. Its research content involves materials science, life sciences, chemistry, biology, anatomy, pathology, clinical medicine, pharmacology, and other disciplines. They are involved in engineering technology and management science.
Biological materials include synthetic materials and natural materials; there are single materials, composite materials, and hybrid materials composed of living cells or natural tissues combined with inanimate materials. The biological material itself is not a drug, and its treatment method is based on the direct combination and interaction with the biological body as its basic feature.
Global Biomaterials Market projected to grow with a momentous rate during the forecast period, 2020-2027. The rise in demand for implantable devices and increasing demand for biomaterials in plastic surgery and wound healing applications would propel the growth of the global biomaterials market in the upcoming years. Moreover, the surge in the increasing prevalence of musculoskeletal and chronic skeletal medical conditions will boom the global biomaterials market size in the future time. Additionally, the upsurge in the incidence of cardiovascular and orthopedic diseases coupled with the growing elderly population across the world are key factors estimated to influence the global biomaterials market.
With the development of science and technology and the aging of the population, the increase in the trauma of young and middle-aged people, the increase of patients with complicated diseases, and the increase in trauma caused by industry, transportation, sports, etc., people are increasingly demanding biomedical materials and products. Furthermore, technological advancements in biomaterials have increased their utility in various fields of healthcare, such as bioengineering and tissue engineering, which lead to the impact of the robust growth of the global biomaterials industry in the upcoming years. In addition, the high prevalence of cardiovascular, neurological, & orthopedic disorders, coupled with the rising awareness regarding the advantages of biomaterials products, is expected to drive the biomaterials market across the world.
Many types of biomaterials and tissue-engineered materials have adopted to repair skin and soft tissue defects and to be applied in augmentation for soft-tissue deformity and also deep tissue damage, including burn and plastic surgery as well as other clinical disciplines. Common biomaterials and tissue-engineered materials include wound dressing, silicone rubber, expanded polytetrafluoroethylene, high-density polyethylene, hyaluronic acid for soft tissue repair, and also hydroxyapatite for hard tissue repair.
With the development of biomaterial technology, biological dressings with different functions can be used to replace traditional dressing replacement methods, and to achieve the purpose of functional reconstruction, shorten the treatment cycle, and reduce the pain of patients.
According to WHO, around 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke. WHO also states that by 2030, an estimated 23.6 million people would die from CVDs, mainly from stroke and heart disease. These are anticipated to remain the single leading causes of death.
In recent years, the use of a large number of biomedical devices based on biomaterials such as interventional medical catheters, vascular stents, and occluders has greatly enriched the treatment of cardiovascular diseases and effectively improved the quality of human life.
Biomaterials have been developed as a science with various forms of implants. They have been widely used to replace and/or restore the function of traumatized or degenerated tissues or organs. The implant/medical device scope of biomaterials ranges from simple implants like intraocular lenses sutures, wound dressings, decellular matrices, bone plates, joint replacements to more complex materials like biosensors, catheters, pacemakers, blood vessels, artificial heart, left ventricular assist devices and prosthetic arterial grafts.
Based on type, the global Biomaterials Market classified into Metallic, Ceramic, Polymeric, and Natural. The Metallic segment witnessed a higher market share in 2019 and predicted to gain major revenue by 2027, owing to the use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications.
Polymeric segment estimated to drive in the forecast period due to biomaterials used for bio-resorbable tissue fixation and other orthopedic applications.
Natural segment projected to surge in the forecast period attributable to their benefits such as biodegradability, biocompatibility, and remodeling for which they are used to replace or restore the structure and function of damaged organs or tissues.
Based on application, the global Biomaterials Market classified into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology, and Others. The Cardiovascular segment accounted for a major share of the biomaterials in 2019. It is primarily attributable to the growing prevalence of cardiovascular diseases, escalating the geriatric population, coupled with the growing adoption of cardiac stents, pacemakers, and implantable cardiac defibrillators.
The Orthopedic segment will grow on account of its high load-bearing capacity. The biomaterials are helpful in orthopedic applications.
Based on geography, the global Biomaterials Market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2027, owing to the rising prevalence of cardiovascular diseases, tissue engineering, and plastic surgery in these regions.
The Asia Pacific will be the fastest-growing segment due to the growing healthcare industry, mounting the geriatric population in emerging countries coupled with the growing prevalence of cardiovascular diseases in these regions.
Companies such as Royal DSM, BASF SE, Corbion, Carpenter Technology Corporation, Evonik Industries, Berkeley Advanced Biomaterials, Cam Bioceramics B.V., Celanese Corporation, CoorsTek Inc. CeramTec, Medtronic plc, Invibio Ltd., Zimmer Biomet Holdings, Inc., and GELITA AG are the key players in the Global Biomaterials Market.